🧠 AI in neurology is here - and it’s powerful.
⚡ Stroke on MRI? 93% sensitivity/spec.
🧠 TBI outcomes? >80% accuracy.
🧪 ICH on CT? 92% sens, 94% spec.
📉 Epilepsy EEGs? Detected via AI.
But challenges remain. Clinical integration needs neurologists at the helm. #AI#Neurology
To the stars, with healthy brain & eyes 👁🚀
Solvemed's AI Pupillometry System—validated in microgravity conditions with @IIAS_Space—is redefining SANS detection for astronauts.
#SpaceHealth#SANS#Solvemed#IIAS#AIinSpace
Introducing the PuRe score by Solvemed!
Objective pupillometry, delivering accurate pupil reactivity assessment regardless of lighting conditions.
Scale: 3-5 = Normal, <3 = Sluggish, 0 = Non-reactive.
Enhance your neurological exam with reliable and convenient pupil testing.
Job Alert (yep - a second one)! Seeking a Postdoctoral Senior Research Associate – AI, Biostatistics & Eye Biometrics Please apply here: https://t.co/SSmZ6ODBwY
What else did 👁 get up to at the @NASA Investigators Workshop?
One of the potential medical 'showstoppers' for an exploration-class mission to Mars is the development of the Spaceflight Associated Neuroocular Syndrome, or SANS...
𝐒𝐞𝐞 𝐎𝐮𝐫 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐂𝐨𝐧𝐭𝐫𝐢��𝐮𝐭𝐢𝐨𝐧𝐬 𝐚𝐭 𝐈𝐒𝐂 | We’re proud to present 2 groundbreaking scientific posters at #ISC25, showcasing our latest research in AI-driven neuro-monitoring. Get a sneak peek in today's blog!
#AICriticalCare #HealthcareInnovation
We are proud to conclude the clinical trial run jointly with Queen Mary University of London & Barts Health NHS Trust in collaboration with Prof. Alastair Noyce's clinical research group investigating the relationship of our ocular biomarkers and Parkinson’s disease. #MedTwitter
Our Co-Founders, Hugo Chrost (@chrost_hugo) and Dr Michal Wlodarski proudly represented @Solvemed at the Neurocritical Care Society (@neurocritical) Annual Meeting in Phoenix, Arizona!
We are proud to support the #criticalcare community!